Intelligence · Clinical Development
Pipeline search results
Programs matching “budesonide” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 24 pipeline programs matching "budesonide" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Budesonide
Bausch + Lomb Ireland Limited
Colitis, Ulcerative
1 trial -
Budesonide
AstraZeneca
Asthma
1 trial -
Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX
Teva Pharma GmbH
Asthma
1 trial -
Budesonide oral suspension
Takeda
Eosinophilic Esophagitis (EoE)
1 trial -
Budesonide/Formoterol SPIROMAX®
Teva Pharma GmbH
Asthma
1 trial -
Budesonide/Formoterol fumarate dihydrate
Teva Pharma GmbH
Asthma
1 trial -
Budesonide/formoterol Turbuhaler
AstraZeneca
Asthma
1 trial -
Generic Budesonide/Formoterol Fumarate Dihydrate
Teva Pharma GmbH
Asthma
1 trial -
Oral Budesonide Suspension (OBS)
Takeda
Eosinophilic Esophagitis (EoE)
2 trials -
budesonide/formoterol 'as needed' + budesonide placebo bid
AstraZeneca
Asthma
1 trial -
Budesonide
LIGAND PHARMACEUTICALS INC
Seasonal Allergic Rhinitis
1 trial -
Budesonide + Azelastine
LIGAND PHARMACEUTICALS INC
Seasonal Allergic Rhinitis
1 trial -
Oral Budesonide Suspension (MB-9)
Takeda
Eosinophilic Esophagitis (EoE)
1 trial -
budesonide
Takeda
Eosinophilic Esophagitis (EoE)
1 trial -
Budesonide
Takeda
Healthy Volunteers
1 trial -
Budesonide
Ferring Pharmaceuticals
Healthy
1 trial -
BUDESONIDE
The George Institute
Chronic obstructive pulmonary disease (COPD)
1 trial -
Budesonide 200 microgram/Puff, HFA MDI
The First People's Hospital of Lianyungang
Asthma
1 trial -
Budesonide-Surfactant
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Premature Infants
1 trial -
Salmeterol/fluticasone propionate or formoterol/budesonide
GlaxoSmithKline
Asthma
1 trial -
Symbicort Turbuhaler (budesonide/formoterol) 320/9 μg
AstraZeneca
Chronic Obstructive Pulmonary Disease (COPD)
1 trial -
budesonide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Respiratory Distress Syndrome
1 trial -
budesonide/formoterol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cough Variant Asthma
1 trial -
Budesonide/formoterol
The First People's Hospital of Lianyungang
COPD Exacerbation
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.